Press Releases March 29, 2026 08:00 PM

Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors

Teladoc Health strengthens leadership with appointment of healthcare industry veteran Susan Salka to board

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
TDOC

Teladoc Health has appointed Susan Salka, former President and CEO of AMN Healthcare Services, to its board of directors. Salka brings extensive experience in healthcare leadership and governance, expected to support Teladoc's growth and transformation in virtual care. She will join audit and compensation committees and succeeds retiring board members, contributing to strategic oversight in an evolving healthcare sector.

Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors
TDOC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Susan Salka, a seasoned healthcare executive with 33 years at AMN Healthcare, joins Teladoc's board, enhancing leadership expertise.
  • Her experience includes managing healthcare workforce technology and multiple acquisitions driving significant revenue growth.
  • This leadership addition supports Teladoc's mission to transform virtual care and improve health outcomes at scale.

NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Susan Salka to its board of directors, effective immediately. Ms. Salka is the former president and CEO of AMN Healthcare Services, a provider of healthcare workforce technology solutions and staffing services to healthcare facilities across the US. She joins following the retirements of Eric Evans and Thomas McKinley and the appointment of Michael Smith. She will serve on the board’s audit and compensation committees.

“Susan brings a powerful combination of healthcare leadership and governance experience to the Board,” said Kenneth H. Paulus, non‑executive Chairman of the Teladoc Health board. “We will benefit from her insights on care delivery transformation as the company drives health outcomes at scale and creates durable value.”

During her 33-year tenure at AMN Healthcare, Ms. Salka was one of the driving forces behind the company's strategic and operational success. AMN pioneered the evolution of workforce solutions and made 26 acquisitions to meet the changing needs of clients, transforming the company and growing revenue to over $5 billion.

Ms. Salka currently serves on the board of Parexel International and previously served on the boards of McKesson Corporation, Beckman Coulter and Playtex Products. She holds an MBA in Finance from San Diego State University and a BA in Accounting and Economics from Chadron State College.

“Integrated, outcomes focused care is central to creating lasting value in healthcare,” said Salka. “Teladoc Health is an innovative leader and I look forward to contributing strategic and operational perspectives on the company’s next phase of growth.”

About Teladoc Health

Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.

Investors:
Michael Minchak
IR@teladochealth.com
617-444-9612

Media:
Lou Serio
PR@teladochealth.com
202-569-9715


Risks

  • Integration challenges in leveraging Susan Salka's experience within Teladoc's existing board dynamics and corporate strategy.
  • Continued competitive pressures in virtual healthcare requiring effective governance and strategic agility.
  • Dependence on healthcare policies and reimbursement landscape affecting virtual care adoption rates.

More from Press Releases

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems Jun 6, 2026 All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration Jun 6, 2026 Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress Jun 6, 2026 InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering Jun 5, 2026 Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 5, 2026